How much funding has PerpetualMeds raised?

PerpetualMeds has raised $8.0M in total funding, most recently a Seed round.

Who are PerpetualMeds's investors?

PerpetualMeds's investors include Chengwei Ventures.

When was PerpetualMeds founded?

PerpetualMeds was founded in 2023.

Where is PerpetualMeds headquartered?

PerpetualMeds is headquartered in Shanghai, China.

What industry is PerpetualMeds in?

PerpetualMeds operates in Artificial Intelligence, Biotech.

How many employees does PerpetualMeds have?

PerpetualMeds has 1-10 employees.

PerpetualMeds

Shanghai, China · Founded 2023 · $8.0M raised

Artificial Intelligence

Biotech

Headquarters: Shanghai
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: perpetualmeds.com
Total Funding: $8.0M
Last Round: $8.0M SeedNov 2023
Rounds: 1

About

Perpetual Medicines is a fully integrated computational peptide therapeutics company building a next-generation peptide drug discovery engine. The company's platform combines leading-edge computational physics methods — including free energy perturbation (FEP) and quantum chemistry — with next-generation AI technologies and advanced synthetic chemistry to access vast, unexplored peptide chemical space. The platform is designed to address previously undruggable targets, accelerate drug discovery, and enhance the quality of peptide drug candidates. Founded in March 2023, the company has operations in Shanghai, China and Boston, MA, and completed an $8 million Seed round in November 2023. In July 2025, Perpetual Medicines announced a strategic merger with TandemAI to expand physics- and AI-based drug discovery capabilities.

Summary

PerpetualMeds is an Artificial Intelligence company based in Shanghai, China, founded in 2023. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Nov 2023. Investors include Chengwei Ventures.